Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Doctors track active bone breakdown using blood and urine bone turnover markers, most commonly serum CTX (C-terminal telopeptide of type I collagen), which reflects how quickly osteoclasts are dissolving bone, alongside formation markers like P1NP, bone-specific alkaline phosphatase, and osteocalcin that show how much new bone is being built. Because these levels shift with fasting status, time of day, kidney and thyroid function, recent fractures, medications, and menopause, results are interpreted as trends over months rather than as a single snapshot, and they help gauge whether treatments such as bisphosphonates or denosumab are working. There are several important factors that affect accuracy and interpretation, so see below to understand more before drawing conclusions about your own numbers.
If you have bone pain, unexplained fractures, height loss, or lab results you do not fully understand, mapping your symptoms first can help you ask sharper questions and avoid unnecessary delays in care. Take a free, instant, online symptom check to clarify what may be driving your symptoms and what steps to take next.
Last reviewed for medical accuracy: 08/18/2026
Maintaining strong bones is essential for mobility, posture and overall quality of life. Bones are dynamic tissues that rebuild and reshape themselves in a process called bone remodeling. When this balance is tipped toward breakdown, you risk conditions like osteoporosis. To keep track of how quickly your bones are being broken down and rebuilt, doctors use bone turnover markers—most notably the CTX and P1NP blood tests.
Bone turnover markers are substances released into the bloodstream during bone formation and resorption (breakdown). Measuring these markers gives a snapshot of how active each process is:
By comparing CTX and P1NP levels, your doctor can see whether bone loss is outpacing bone formation—or vice versa.
Monitoring CTX and P1NP helps in several ways:
Both CTX and P1NP are measured with a simple blood draw, usually in the morning after an overnight fast. Here’s what to expect:
Marker levels can vary by age, sex and lab methods. Your doctor will compare your CTX and P1NP values to reference ranges and track changes over time. Key points include:
Always review results with your doctor rather than relying on raw numbers alone.
Several factors can affect CTX and P1NP readings:
Your doctor will factor in these variables when planning tests and interpreting changes.
Bone marker testing is most useful:
Routine testing beyond a stable treatment plan is less common unless new symptoms arise.
While valuable, bone turnover markers aren’t perfect:
Markers should always be part of a broader assessment that includes medical history, fracture risk calculators and imaging.
Beyond monitoring, here’s how you can support bone health:
It’s wise to monitor symptoms that might hint at serious bone issues. You can do a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide when to seek medical advice.
Bone health involves more than just numbers. If you experience any of the following, talk to your doctor right away:
For anything that could be life threatening or serious, always seek immediate medical attention.
CTX and P1NP blood tests offer a window into the inner workings of your bones. By measuring the rates of bone resorption and formation, these markers guide early detection, personalized treatment and ongoing monitoring of conditions like osteoporosis. Remember:
If you have concerns about bone breakdown or treatment progress, speak to a doctor to review your CTX and P1NP results and plan the next steps in your bone-health journey.
(References)
* Eyre D. New biomarkers of bone resorption. J Clin Endocrinol Metab. 1992 Mar;74(3):470A-470C. doi: 10.1210/jcem.74.3.1740477. PMID: 1740477.
* Takahashi M, Inoue T. [Bone resorption markers]. Rinsho Byori. 1996 May;44(5):415-22. PMID: 8676559.
* Cantatore FP, Pipitone V. Markers of bone turnover: consideration on their clinical application in osteoporosis. Panminerva Med. 1999 Sep;41(3):247-51. PMID: 10568124.
* Johnell O, Odén A, De Laet C, Garnero P, Delmas PD, Kanis JA. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int. 2002 Jul;13(7):523-6. doi: 10.1007/s001980200068. PMID: 12111011.
* Cox G, Einhorn TA, Tzioupis C, Giannoudis PV. Bone-turnover markers in fracture healing. J Bone Joint Surg Br. 2010 Mar;92(3):329-34. doi: 10.1302/0301-620X.92B3.22787. PMID: 20190300.
* Korpi-Steiner N, Milhorn D, Hammett-Stabler C. Osteoporosis in men. Clin Biochem. 2014 Jul;47(10-11):950-9. doi: 10.1016/j.clinbiochem.2014.03.026. Epub 2014 Apr 12. PMID: 24726494.
* Miura M, Satoh Y. [Bone turnover marker]. Nihon Rinsho. 2015 Oct;73(10):1649-58. PMID: 26529926.
* Baloul SS. Osteoclastogenesis and Osteogenesis during Tooth Movement. Front Oral Biol. 2016;18:75-9. doi: 10.1159/000351901. Epub 2015 Nov 24. PMID: 26599120.
* Szulc P. Bone turnover: Biology and assessment tools. Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):725-738. doi: 10.1016/j.beem.2018.05.003. Epub 2018 May 26. PMID: 30449551.
* Wang S, Mu R, Zhang X, Yun K, Shang H, Zhao M. Biological variation in serum bone turnover markers. Ann Clin Biochem. 2020 Mar;57(2):144-150. doi: 10.1177/0004563219899119. Epub 2020 Jan 8. PMID: 31842583.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.